How do the new antithrombotic recommendations affect your HBR patients?
Gain insights from a patient case analysis
30 octobre 2023 - 17h00 - 18h00
Gain insights from a patient case analysis
Introduction
In this program, we will discover how recent guidelines updates impact antithrombotic treatment options for high bleeding risk (HBR) patients. A detailed analysis of a complex patient case will uncover its practical implications.
Agenda
|
5.00 pm
|
Introduction & patient case presentation
|
| 5.05 pm |
Analyse a complex patient case to understand guideline implications on your daily practice
|
| 5.45 pm |
Panel Discussion & Take Home message
|
Objectives
- To understand the influence of the new ESC ACS guidelines on antithrombotic treatment for HBR patients in your practice
- To discuss on how to navigate between high ischemic and high bleeding risk
- To refer to new guidelines, review evidence and study emerging data to guide treatment choices